Severe Aortic Stenosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 The patient gives informed consent and signs the informed consent form, committing to adhere to the research procedures. 2 All participants are over 50 years old. 3 Patients who meet conventional TAVR indications 4 Patients are pre-procedurally assessed to be at high risk for coronary obstruction or are intraprocedurally confirmed to have a risk of coronary obstruction.
Exclusion criteria
Exclusion criteria: 1 Contrast agent allergy or eGFR < 30 ml/min/1.73 m^2 2 Life expectancy < 1 year, 3 Severe missing data, 4 Loss to follow-up, 5 Contraindications to contrast agents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In-Stent Restenosis;Target Lesion Failure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Stent Thrombosis;Major Adverse Cardiovascular Events; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology